Alembic Pharmaceuticals Incorporates Step-Down Subsidiary Alvesta Pharmaceuticals in UAE
Alembic Pharmaceuticals Ltd 路 Others (Uncategorized) 路 20 Oct 2026, 12:50 am
Alembic Pharmaceuticals Incorporates Step-Down Subsidiary Alvesta Pharmaceuticals in UAE Alembic Pharmaceuticals' wholly owned subsidiary, Alembic Global Holding SA, incorporated a step-down wholly owned subsidiary, Alvesta Pharmaceuticals FZCO, in Dubai, UAE, on 1st Sep'26. The new entity was formed via cash consideration of AED 100,000, comprising 100 shares at AED 1,000 each, giving Alembic 100% control. The entity will operate in the pharmaceutical industry to explore new business opportunities and manage the promotion, sale, and distribution of the company鈥檚 pharmaceutical products.
Original exchange filing (PDF)
More announcements from Alembic Pharmaceuticals Ltd
- Alembic Pharmaceuticals Limited receives USFDA Final Approval for Binimetinib Tablets, 15 mg and 45 mg. 路 15 Nov 2026
- Please find attached herewith the Transcript of Post Results Conference Call held on 4th November, 2026. 路 10 Nov 2026
- Alembic Pharmaceuticals Limited receives USFDA Final Approval for Olopatadine Hydrochloride Ophthalmic Solution USP, 0.7% (OTC). 路 05 Nov 2026
- Please find attached Audio Recording of Investor Call. 路 05 Nov 2026
- Please find attached intimation under Regulation 30(5) of SEBI (LODR) Regulations, 2015. 路 04 Nov 2026
- Please find attached Press Release 路 04 Nov 2026
- Please find attached Investor Presentation for the Quarter and Half Year Ended September 30, 2026. 路 04 Nov 2026
- Please find attached Press Release for the Quarter and Half Year Ended September 30, 2026. 路 04 Nov 2026
